Biochemical parameters
Fig 1 represents the blood sugar level in Wistar rats treated or not by carrageenan. Compared with the rats of the negative control group, carrageenan increased the blood sugar level in the rats of the second group with a rate of 68.51%. A significant decrease (P<0.05) of this parameter is noted in the rats of the G4 group (47.91%), which received 200mg/kg of the ethanolic extract of
Taraxacum officinale (EET) compared to the ratio to the second group.
High glucose levels in rats of group G2 (injected only with carrageenan), that inflammation can unbalance diabetes and
Taraxacum officinale exerts a protective and preventive effect against carrageenan-induced hyperglycemia.
Ribezzo et al., (2016) show that oxidative stress plays a key role in the perpetuation of inflammation and by the release of cytokines and is observed in various diseases such as cardiovascular diseases, neurodegenerative diseases as well as diabetes that hyperglycemia is one of these signs, which is explained by the results of the positive control group.
Davaatseren et al., (2013) show that
Taraxacum officinale has an antidiabetic role. Total proteins The serum concentrations of total proteins are reported in Fig 2.
Through the results obtained, the injection of carrageenan in G2 resulted in a significant decrease (P<0.05) in the total protein level which is of the order of 4.7 g/dl compared to the control group (G1) (8.1 g/dl).
On the other hand, there is a significant increase (P<0.05) observed in rats pretreated with EET (G4), whose levels of total proteins (44.26%) are higher almost 2 times than those recorded in rats of the positive control group G2.
Fig 3 represents the serum albumin concentrations. Our results show that the administration of the EET extract does not significantly affect the albumin levels in group G3 (4.54 g/dl), these are almost similar for the negative control group G1 (4.4 g/dl).
However, the intradermal injection of carrageenan significantly modified (P<0.05) the proportions of albumin in G2 animals, decreasing their levels with a rate of 61.36% compared with G1. And a significant increase (P<0.05) in the albumin level in rats pretreated with 200 mg/kg of ethanolic extract of
Taraxacum officinale then injected with 100 µl of carrageenan of the order of 61.36% compared with G1.
Total proteins mainly include albumin, globulins (alpha 1, alpha 2, beta, gamma) are synthesized by the liver (
Belier and Michaux, 2007). During tissue inflammation, there is normally vasodilation and capillary recruitment and at least transient increases in capillary permeability. This leads to extravasation of plasma proteins (
Carlsson and Rippe, 1999) which was observed in the group subjected to inflammation (hypoalbuminemia and hypoproteinemia).
The plasma fibrinogen concentrations of rats exposed to inflammation are shown in Fig 4. According to our results, it is noted that the fibrinogen concentration increased significantly (P<0.05) by 75.86% in animals that received only a carrageenan injection at the paw (G2) compared to the control group (G1). In comparison with rats in group G2, the EET decreased the fibrinogen concentration in rats of group 4 with a level of 37.93%.
Fibrinogen is a soluble protein synthesized by the liver.It is a marker of inflammation (
Louisot, 1983) so the increase in fibrinogen in the positive control group (G2) compared to the control group (G1) is a sign of the onset of inflammation.
Antioxidant status
The malondialdehyde level of the different groups is presented in Fig 5.
A very high level of malondialdehyde (68.51%) is noted in rats of group G2 injected with carrageenan compared to rats of the control group G1. Compared with the MDA level of rats of group G2, rats of group G4 pretreated with EET then carrageenan showed a reduced level of 48.14%. Our observations are in line with those obtained by (
Park et al., 2011) who suggest that the two ‘extracts: aqueous and methanolic of
T. officinale root have a protective action by reducing lipid peroxidation (MDA) which observed in rats of the group pretreated with the ethanolic extract of
Taraxacum officinale then undergone inflammation with carrageenan.
Oxidative status: Catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) levels
A highly significant (P<0.05) reduction in the enzymatic activity of catalase, superoxide dismutase and glutathione peroxidase to respective levels of 50.77;78.29 and 50.29% is due to intradermal injection of carrageenan which induced inflammation in G2 rats compared to the control group (G1) (Fig 6,7 and 8). Furthermore, daily administration of EET at a dose of 200mg/kg attenuated carrageenan-induced inflammation in (G4) animals at estimated increases in the enzymatic activity of CAT, SOD and GSH Pxof the order of 57.40 ; 79.56 and 56.98% respectively, compared to G2.
Superoxide radical produced during mitochondrial electron transport chain or as a product of nitric oxide synthase, NADPH and xanthine oxidase. Nitric oxide is formed by NO synthase from L-arginine and molecular oxygen. O
2 is dismutated by superoxide dismutase SOD to H
2O
2 which is then converted to OH or detoxified by catalase to water. In addition, NO and O
2 react spontaneously and rapidly to form peroxynitrite (ONOO)
(Kandikattu et al., 2015; Hausladen and Stamlert, 2017).
Antioxidants recovered from medicinal plants and enzymes of different derivatives from various biological sources such as catalase, peroxidases and superoxide dismutase play an important role in minimizing the rate of oxidation of other compounds (
D’Angelo, 2009).
Our results show the anti-inflammatory effect of the EET and they corroborate with that
(Park et al., 2011) which suggest that the ethanolic and aqueous extract of
Taraxacum officinale reduced antioxidant enzyme activities including: Superoxide dismutase, catalase, GSH-peroxidase and GSH-reductase.
Biomarkers of inflammation
- Prostaglandin E2 (PGE2) levels
Fig 9 shows the prostaglandin levels in rats treated or not with the ethanolic extract of
Taraxacum officinale and/or carrageenan Rats in group G2 treated only with carrageenan recorded a very significant increase (P<0.05) in the serum level of PGE2 of 60.67%, compared to the control group G1. While group G4 (which received 200 mg/kg of EET) showed a significant decrease of 20.95% in the concentration of PGE2 compared to the positive control group G2.
- TNF-α Levels
The level of tumor necrosis factor TNF-α ng/g in rats treated or not with the EET and/or carrageenan is shown in Figure 10. According to our results shown in the following figure, it is noted that there is a significant increase (P<0.05) (47.45%) in the serum level of TNF-α in rats of the second group G2 (which were injected with carrageenan only) compared to rats of the first group G1 (86.2 ng/g). Compared with the level of rats of group G2, rats of group G4 pretreated with EET extract and then carrageenan showed a reduced level of 23.75%.
Inflammation is a complex biological process that acts as a primary defense system to counteract harmful stimuli against foreign organisms such as bacteria and viruses. The inflammatory mechanism induces IKK and p-65 which activates cytokines and releases prostaglandins (PGE)
(Loram et al., 2007; Turner et al., 2014).
Then inflammation is confirmed in the positive control group leading to a significant increase in prostaglandin levels because
Bahmani et al., (2014) reported that flavonoids have effects on opioid receptors and alpha-adrenergic receptors which can inhibit enzymes involved in inflammation and pain. In addition, flavonoids in inflamed tissues inhibit cyclooxygenase, so they can prevent the formation of prostaglandins (PGE)
Pilehvarian et al., (2010).
This was recorded in rats in the group pretreated with 200 mg/kg of EET because our plant is rich in flavonoids. Our results corroborate those of
Liu et al., (2010) who show that
Taraxacum officinale also inhibits the production of inflammatory cytokines TNF 6 hours after lipopolysaccharide challenge in a dose-dependent manner in mice.
Histological study
Microscopic observation carried out on a topographical staining of histological sections of paws reveals the inflammatory action due to the injection of 100 µL of carrageenan intradermally (G2) at the level of the paw of rats Fig 11. This chronic inflammation is reflected at the level of tissue architecture by the presence of congestions, associated with edema between the muscle bundles at the level of the deep dermis (Fig 11 G2). Furthermore, an architectural aspect showing a normal striated muscle of the legs of the rats of the G3 group (which received only 200 mg/kg of
Taraxacum officinale) as almost that of the control group (G1) (Fig 11 G3). However, the rats of G4 responded positively and effectively to the pre-treatment by the EET extract from which their structures seem to be restored compared to that found in the positive control group (Fig 11 G4).
Liu et al., (2010) showed that
Taraxacum officinale has been frequently used as a remedy for inflammatory diseases. The administration of (250 mg/kg) dandelion has a beneficial effect in decreasing catalase, glutathione peroxidase and superoxide dismutase, reducing lipid peroxidation (
Omür et al., 2017).
Our results are corroborated with those of
Onoja et al., (2017) with the methanolic extract of
Justicia secunda leaves.
Hu and Kitts (2004) confirm that
Taraxacum officinale contains luteolin which is possessed an anti-inflammatory effect.
Jeon et al., (2008) demonstrated that
Taraxacum officinale can be used in anti-inflammatory therapy with the advantage of having fewer side effects. Inflammation is a complex pathophysiological process mediated by various signaling molecules produced by leukocytes, macrophages and mast cells
(Aoki et al., 2008).
Symptoms result from increased blood flow to damaged or infected tissues, causing fever, redness, swelling and pain. Macrophages are major inflammatory cells and immune effector cells. A major function of macrophages is the phagocytosis of cellular and acellular debris during inflammation and healing
(Scull et al., 2010).
Activated macrophages are present in inflamed tissues and play an important role in inflammatory disease
via the release of inflammatory mediators.
Taraxacum officinale has long been used as a medicinal plant to treat inflammatory diseases such as hepatitis, arthritis, rheumatism, breast abscess, lung abscess, intestinal abscess, scrofula, sore throat and swelling (
Schütz et al., 2006;
Park et al., 2011).
In addition, various studies on
Taraxacum officinale extracts and their components have demonstrated anti-inflammatory, antinociceptive, antioxidant and anticancer activities
(Jeon et al., 2008; Choi et al., 2010; You et al., 2010), which is consistent with the results obtained during this work.